ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of actein derivatives as potent anti-triple negative breast cancer agents

Zhang, Honglin; Chen, Yiyan; Huang, Songwen; Xiao, Wen-Wen; Qiu, Ming-Hua*; Shao, Li-Dong*; Chen, Chuan-Huizi*; Li, Dashan*云南大学
Bioorganic and Medicinal Chemistry Letters2023-6-1DOI: 10.1016/j.bmcl.2023.129307
1被引8阅读
引用收藏
分享

摘要

Actein is a natural triterpenoid glycoside, isolated from the rhizomes of Cimicifuga foetida, which have been demonstrated to be potential in the treatment of breast cancer previously. Herein, we described the design and synthesis of a series of actein derivatives as anti-triple negative breast cancer (TNBC) inhibitors. Of which, the most promising derivative 27 exhibited significant inhibitory activity against human TNBC cell lines HCC1806 and MDA-MB-231, with IC50 values of 2.78 and 9.11 mu M, respectively. Structure-activity relationships of actein derivatives were also discussed. Moreover, preliminary mechanism investigation revealed that 27 significantly inhibited cancer cell proliferation via cell cycle arrest at S phase. In addition, western blot analysis showed that the activation of MAPK signaling pathway might contribute to derivative 27 induced cell death. Overall, these results indicate that 27 has the potential to be developed as a lead compound and compounds with the actein scaffold are a promising novel class of inhibitors to treat TNBC.

学科与关键词

关键词
ActeinModificationTriple negative breast cancerStructure-activity relationshipsMechanism
相关
加载中…
  • Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives
    Zhang, Honglin; Chen, Yiyan; Liu, Qiuyu; Xiao, Wen-Wen; Shao, Li-Dong*; Pan, Zheng-Hong*; Chen, Chuan-Huizi*; Li, Dashan*Bioorganic and Medicinal Chemistry Letters, 2023, 83: 129187.
  • In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
    Lin, Jinrong; Qu, Zhao*; Pu, Huanhuan; Shen, Li-Sha; Yi, Xianguo; Lin, Yu-Shan; Gong, Rui-Hong; Chen, Guo-Qing*; Chen, Sibao*MOLECULES, 2023, 28(23): 7701.
  • Cytotoxic Compounds from Belamcanda chinensis (L.) DC Induced Apoptosis in Triple-Negative Breast Cancer Cells
    Guo, Ya-Ping; Yi, Peng; Shi, Qi-Qi; Yu, Rui-Rui; Wang, Jin-Hui; Li, Chen-Yang*; Wu, Hai-Qiang*MOLECULES, 2023, 28(12): 4715.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic and Medicinal Chemistry Letters
发表日期
2023-06-01
卷期
第 89 卷
页码
129307
DOI
10.1016/j.bmcl.2023.129307
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81803396]; Yunnan Fundamental Research Project [202001AS070038]; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine [202101AZ070001-217, 202001AZ070001-089]; Yunnan Talents Support Plan-Young Talents Project; Bioactive Ethnopharmacol Molecules Chemical Conversion and Application Innovation Team of Department of Education of Yunnan Province [2022]; Start-up Fund of Yunnan University of Chinese Medicine [2019YZG03]

作者

  • Z

    Zhang, Honglin (第一作者)

    yunnan univ

  • C

    Chen, Yiyan

    yunnan univ

查看全部 8 位作者收起作者
  • H

    Huang, Songwen

  • X

    Xiao, Wen-Wen

  • Q

    Qiu, Ming-Hua (通讯)

    chinese acad sci, kunming inst bot

  • S

    Shao, Li-Dong (通讯)

    yunnan univ

  • C

    Chen, Chuan-Huizi (通讯)

    yunnan univ

  • L

    Li, Dashan (通讯)

    yunnan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417